In the available data, 5-Amino-1MQ has generally been reported as well-tolerated but generally well-tolerated in limited data is not the same as proven safe for everyone. Human safety data is still limited, long-term effects aren't fully characterized, and that uncertainty is itself a reason for medical oversight
Patients taking GLP-1 drugs lose weight faster, but they may experience side effects, such as nausea, vomiting, diarrhea, indigestion, fatigue, dizziness, and hypoglycemia, along with other potential adverse events
That is a deliberately narrow claim: the number is what the protocol says, the math shows exactly how it converts to a syringe draw, and everything about whether the compound does anything in a human is left to the honest evidence section rather than smuggled into the dose
Pharmaceutical form and presentation IM injectable and drinkable solution
The standard protocol uses 2.8 mg per injection: 2 mg GHK-Cu + 400 mcg of BPC-157 + 400 mcg of TB-4
The typical form of B12 used in doctors offices is cyanocobalamin, a cheaper and subpar form of B12